Depreciation of Vitro Biopharma, Inc. from 31 Oct 2011 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vitro Biopharma, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Oct 2011 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Depreciation for the quarter ending 31 Oct 2025 was $19,022, a 53% decline year-over-year.
  • Vitro Biopharma, Inc. Depreciation for the twelve months ending 31 Oct 2025 was $102,555, a 43% decline year-over-year.
  • Vitro Biopharma, Inc. annual Depreciation for 2025 was $102,555, a 43% decline from 2024.
  • Vitro Biopharma, Inc. annual Depreciation for 2024 was $180,862, a 18% increase from 2023.
  • Vitro Biopharma, Inc. annual Depreciation for 2023 was $153,023, a 6.6% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Vitro Biopharma, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $102,555 $19,022 -$21,742 -53% 01 Aug 2025 31 Oct 2025 10-K 13 Feb 2026 2025 FY
Q2 2025 $124,297 $21,565 -$26,748 -55% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2025 Q3
Q1 2025 $151,045 $24,534 -$23,707 -49% 01 Feb 2025 30 Apr 2025 10-Q 20 Jun 2025 2025 Q2
Q4 2024 $174,752 $37,434 -$6,110 -14% 01 Nov 2024 31 Jan 2025 10-Q 20 Mar 2025 2025 Q1
Q3 2024 $180,862 $40,764 +$5,485 +16% 01 Aug 2024 31 Oct 2024 10-K 13 Feb 2026 2025 FY
Q2 2024 $175,377 $48,313 +$8,607 +22% 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2025 Q3
Q1 2024 $166,770 $48,241 +$8,566 +22% 01 Feb 2024 30 Apr 2024 10-Q 20 Jun 2025 2025 Q2
Q4 2023 $158,204 $43,544 +$5,181 +14% 01 Nov 2023 31 Jan 2024 10-Q 20 Mar 2025 2025 Q1
Q3 2023 $153,023 $35,279 -$4,859 -12% 01 Aug 2023 31 Oct 2023 10-K 28 Jan 2025 2024 FY
Q2 2023 $157,882 $39,706 -$8,562 -18% 01 May 2023 31 Jul 2023 10-Q 16 Sep 2024 2024 Q3
Q1 2023 $166,444 $39,675 -$12,749 -24% 01 Feb 2023 30 Apr 2023 10-Q 31 May 2024 2024 Q2
Q4 2022 $179,193 $38,363 +$15,394 +67% 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024 2024 Q1
Q3 2022 $163,799 $40,138 01 Aug 2022 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $48,268 01 May 2022 31 Jul 2022 10-Q 28 Aug 2023 2023 Q3
Q1 2022 $52,424 01 Feb 2022 30 Apr 2022 10-Q 13 Jun 2023 2023 Q2
Q4 2021 $22,969 01 Nov 2021 31 Jan 2022 10-Q 14 Mar 2023 2023 Q1

Vitro Biopharma, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $102,555 -$78,307 -43% 01 Nov 2024 31 Oct 2025 10-K 13 Feb 2026 2025 FY
2024 $180,862 +$27,839 +18% 01 Nov 2023 31 Oct 2024 10-K 13 Feb 2026 2025 FY
2023 $153,023 -$10,776 -6.6% 01 Nov 2022 31 Oct 2023 10-K 28 Jan 2025 2024 FY
2022 $163,799 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY
2015 $12,604 -$1,864 -13% 01 Nov 2014 31 Oct 2015 10-K 22 Sep 2016 2015 FY
2014 $14,468 01 Nov 2013 31 Oct 2014 10-K 22 Sep 2016 2015 FY
2012 $16,948 -$525 -3% 01 Nov 2011 31 Oct 2012 10-K 12 Feb 2013 2012 FY
2011 $17,473 01 Nov 2010 31 Oct 2011 10-K 12 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.